Mesenchymal-Mode Migration Assay and Antimetastatic Drug Screening with High-Throughput Microfluidic Channel Networks

Droplet Microfluidics-A Tool for Single-Cell Analysis

(2012) Haakan N. Joensson et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells

(2012) W. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Microfluidics for Manipulating Cells

(2012) Xuan Mu et al.   Small

Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers

(2011) Shutao Wang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration

(2011) Yu Huang et al.   Biomicrofluidics

Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice

(2011) S. Gingis-Velitski et al.   CANCER RESEARCH

Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells

(2011) Piyush B. Gupta et al.   CELL

Automatic transwell assay by an EIS cell chip to monitor cell migration

(2011) Elisabetta Primiceri et al.   LAB ON A CHIP

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Microfluidic devices for studying chemotaxis and electrotaxis

(2011) Jing Li et al.   TRENDS IN CELL BIOLOGY

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

(2011) Dejuan Kong et al.   Cancers

The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system

(2010) Eliza Wiercinska et al.   BREAST CANCER RESEARCH AND TREATMENT

Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8

(2010) Yoshihiro Yui et al.   CLINICAL & EXPERIMENTAL METASTASIS

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

Mesenchymal Migration as a Therapeutic Target in Glioblastoma

(2010) Jessie Zhong et al.   Journal of Oncology

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Moving targets: cell migration inhibitors as new anti-inflammatory therapies

(2008) Charles R Mackay   NATURE IMMUNOLOGY

Paclitaxel plus Bevacizumab for Metastatic Breast Cancer

(2008)   NEW ENGLAND JOURNAL OF MEDICINE